EAACI Fellow (FEAACI)

EAACI recognizes excellence in basic and clinical research in the field of allergy and clinical immunology and awards the title of EAACI Fellow to EAACI members who have excelled in their field. EAACI fellows will form an elite advisory board that will be called upon by the Academy on various matters in future years.

About

EAACI recognizes excellence in basic and clinical research in the field of allergy and clinical immunology and awards the title of EAACI Fellow to EAACI members who have excelled in their field. EAACI fellows will form an elite advisory board that will be called upon by the Academy on various matters in future years.

EAACI Fellows are selected each year on the basis of previous research record (h-index) and outstanding contributions to the field of allergy and clinical immunology.

Four fellows (two for clinical excellence and two for research excellence) will be selected in 2024. The award will be presented during the opening ceremony at the upcoming EAACI Congress 2024 in Valencia, Spain from 31 May – 03 June 2024.

Requirements

1) Be an active EAACI member (mandatory)
2) Currently or previously active in EAACI committees, interest groups, sections, guidelines and/or task forces (mandatory)
3) Qualifications*:
a. Score: Scopus h-factor >45 and/or research gate score >45 with 98% based on publications**
b. Leading in large research consortia, i.e. ERC
c. First or senior author in breakthrough papers
d. Leading in clinical guidelines

*At least 2 out of 4 qualifications should apply
**Younger members <45 years can qualify with a lower h-factor when qualification b and/or c applies

Applications for 2024 are closed.

Please note that current Executive Committee Members can not apply for the EAACI Fellow Award.

Contact

For more information please contact:

EAACI Headquarters
Hagenholzstrasse 111
3rd Floor
8050 Zurich
Switzerland
Telephone: +41 44 205 55 33
Email: info@eaaci.org

Fellows list

  • 2023
    Adnan Custovic
    Dr. Durham has been awarded the FEAACI in 2021 for his continuous excellence in research of basic mechanisms of allergic rhinitis and asthma, local IgE regulation and translational clinical and mechanistic studies of allergen immunotherapy.